Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: Performance of a fully automated AI‐algorithm for lesion detection and classification
Open Access
- 4 April 2023
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 83 (9) , 871-878
Abstract
Background: Multiparametric MRI (mpMRI) improves the detection of aggressive prostate cancer (PCa) subtypes. As cases of active surveillance (AS) increase and tumor progression triggers definitive treatment, we evaluated whether an AI‐driven algorithm can detect clinically significant PCa (csPCa) in patients under AS.Methods: Consecutive patients under AS who received mpMRI (PI‐RADSv2.1 protocol) and subsequent MR‐guided ultrasound fusion (targeted and extensive systematic) biopsy between 2017 and 2020 were retrospectively analyzed. Diagnostic performance of an automated clinically certified AI‐driven algorithm was evaluated on both lesion and patient level regarding the detection of csPCa.Results: Analysis of 56 patients resulted in 93 target lesions. Patient level sensitivity and specificity of the AI algorithm was 92.5%/31% for the detection of ISUP ≥ 1 and 96.4%/25% for the detection of ISUP ≥ 2, respectively. The only case of csPCa missed by the AI harbored only 1/47 Gleason 7a core (systematic biopsy; previous and subsequent biopsies rendered non‐csPCa).Conclusions: AI‐augmented lesion detection and PI‐RADS scoring is a robust tool to detect progression to csPCa in patients under AS. Integration in the clinical workflow can serve as reassurance for the reader and streamline reporting, hence improve efficiency and diagnostic confidence.Keywords
This publication has 43 references indexed in Scilit:
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2011
- Pathological Findings at Radical Prostatectomy in Japanese Prospective Active Surveillance CohortJapanese Journal of Clinical Oncology, 2010
- Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate CancerJournal of Clinical Oncology, 2010
- Insignificant Prostate Cancer and Active Surveillance: From Definition to Clinical ImplicationsEuropean Urology, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillanceCancer, 2008
- PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden sectionInternational Journal of Cancer, 2006
- Current practice of Gleason grading of prostate carcinomaVirchows Archiv, 2005
- Active Surveillance for Prostate Cancer: For Whom?Journal of Clinical Oncology, 2005
- Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostateJournal of Magnetic Resonance Imaging, 2005